Ji et al. demonstrated that genistein alleviates NASH in HFD-fed rats by improving liver function, reduced thiobarbituric acid-reactive substances (TBARS), TNF-α, and IL-6 levels, and inhibiting IκB-α/NF-κB and JNK pathways (30). Here, NFKBIA is linked to metabolic dysfunction-associated steatohepatitis.